Form 4: Omada Health Director Acquires Shares

Sentiment:

Statement of Changes in Beneficial Ownership


Omada Health, Inc. reports a transaction where Director Julie D. Klapstein acquired 649 shares of Common Stock.

Summary

  • Director Julie D. Klapstein acquired 649 shares of Omada Health, Inc. Common Stock on July 5, 2026.
  • These shares were acquired as restricted stock units (RSUs) granted under the Issuer's Non-Employee Director Compensation Program, in lieu of retainer fees.
  • Each RSU represents the right to receive one share of Common Stock, with settlement occurring on a date selected by the Reporting Person or as otherwise provided by the program.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it represents a standard compensation-related transaction for a director rather than a significant new investment or divestment.

Positives

  • Director acquisition of shares can signal confidence in the company's future prospects.
  • The acquisition of 649 shares by a director indicates continued engagement and potential alignment of interests with shareholders.

Future Outlook

The filing does not contain specific forward-looking statements or guidance regarding future financial performance. The RSUs are subject to settlement terms defined by the Issuer's Non-Employee Director Compensation Program.

Industry Context

StockSavvy.ai notes that director share acquisitions, particularly through compensation programs, are common within the digital health and wellness industry as a means to attract and retain experienced board members. This transaction aligns with standard practices for compensating non-employee directors.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Director Compensation ProgramRestricted stock units (RSUs) granted to Director Julie D. Klapstein in lieu of retainer fees under the Issuer's Non-Employee Director Compensation Program.07/05/2026Standard practice for director compensation, aligning director interests with company performance.

Related Party Transactions

  • Acquisition of 649 shares of Common Stock by Director Julie D. Klapstein as part of the Non-Employee Director Compensation Program.

Stakeholder Impact

  • Shareholders: The transaction represents a standard compensation practice and does not immediately alter the ownership structure in a significant way. It may reinforce alignment between director and shareholder interests.
  • Employees: No direct impact on employees is indicated by this filing.
  • Management: No direct impact on management is indicated by this filing.

Next Steps

  • Settlement of restricted stock units according to the terms of the Issuer's Non-Employee Director Compensation Program.

Key Dates

DateDescription
07/05/2026Transaction Date for acquisition of Common Stock.
07/07/2026Date of signature for the filing.

Keywords

Omada Health, OMDA, Form 4, Director, Stock Acquisition, Restricted Stock Units, RSU, Beneficial Ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.